Gilead Sciences
US.GILD
151.00
-0.23
-0.15%
Gilead Sciences
151.00
-0.23
-0.15%
Collector offline (last heartbeat: 19169s ago)
· 2026-09-04 20:02
Pre-market
149.28
-1.28%
After-hours
151.00
0.00%
Overnight
150.73
-0.32%
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 9 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 90.92% -0.05pp
- Institutions
- 2,702 -9
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund77.50%
Public Company4.16%
Government Pension Fund2.47%
Hedge Fund2.14%
Private Company2.01%
Sovereign Wealth Fund1.86%
Corporate Pension Plan0.21%
Family Office/Trust0.19%
Government0.13%
Other9.33%
Top holders
| Holder | Stake |
|---|---|
| BlackRock | 9.83% |
| Vanguard Capital Management, LLC | 7.10% |
| State Street Global Advisors | 4.94% |
| Capital Research | 4.90% |
| FMR | 4.75% |
| Other | 68.48% |
Insiders
18 filings tracked · 12 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| Daniel Patrick O'Day | Chairperson & CEO | 0.05% |
| Andrew Dickinson | Chief Financial Officer | 0.01% |
| Johanna Mercier | Chief Commercial Officer | 0.01% |
| Diane Wilfong | Former Senior VP, Corporate Controller & Chief Accounting Officer | 0.00% |
| Deborah Telman | Executive VP of Corporate Affairs, General Counsel & Corporate Secretary | 0.00% |
| Sandra Patterson | Senior VP, Corporate Controller & Principal Accounting Officer | 0.00% |
| Jacqueline Barton | Independent Director | 0.00% |
| Dietmar Berger | Chief Medical Officer | 0.00% |
| Harish Manwani | Independent Director | 0.00% |
| Javier Rodriguez | Independent Director | 0.00% |
Quote time 2026-09-04 20:02:21
For reference only, not investment advice.